Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Re (RMAX) EBIT (2016 - 2025)

Historic EBIT for Re (RMAX) over the last 14 years, with Q3 2025 value amounting to $18.3 million.

  • Re's EBIT rose 2039.31% to $18.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year increase of 6022.89%. This contributed to the annual value of $40.2 million for FY2024, which is 47774.75% up from last year.
  • Latest data reveals that Re reported EBIT of $18.3 million as of Q3 2025, which was up 2039.31% from $14.0 million recorded in Q2 2025.
  • Re's 5-year EBIT high stood at $18.3 million for Q3 2025, and its period low was -$37.6 million during Q3 2021.
  • For the 5-year period, Re's EBIT averaged around $5.0 million, with its median value being $7.6 million (2022).
  • Its EBIT has fluctuated over the past 5 years, first crashed by 50110.79% in 2023, then surged by 17244.02% in 2024.
  • Re's EBIT (Quarter) stood at $10.4 million in 2021, then dropped by 18.88% to $8.5 million in 2022, then plummeted by 214.58% to -$9.7 million in 2023, then surged by 144.03% to $4.3 million in 2024, then soared by 328.78% to $18.3 million in 2025.
  • Its last three reported values are $18.3 million in Q3 2025, $14.0 million for Q2 2025, and $5.4 million during Q1 2025.